Next |
home / stock / zyme / zyme message board
Subject | By | Source | When |
---|---|---|---|
50 million complete...... 325 million potential by the | Brokemillwright | investorshub | 11/30/2022 11:36:11 PM |
All the pumpers run away? Can't believe this | Brokemillwright | investorshub | 10/21/2022 1:53:28 AM |
Its been holding up nicely here! Lets | Clean | investorshub | 06/01/2022 1:53:11 PM |
I believe it does still look promising my friend. | DTGoody | investorshub | 05/27/2022 4:27:47 PM |
Howdy $ZYMEers. The future still looks pretty good here, | budgetthis | investorshub | 05/27/2022 3:30:25 PM |
Looks like it June July calls may pay | DTGoody | investorshub | 05/27/2022 1:56:56 AM |
Glad I waited. I as well didn't | Clean | investorshub | 05/26/2022 4:32:02 PM |
Zyme Rejects Offer. I am Glad I sold | DTGoody | investorshub | 05/20/2022 1:26:20 PM |
ALL BLUE CAPITAL EXPANDS ITS LEADERSHIP TEAM TO | DTGoody | investorshub | 05/19/2022 5:10:31 PM |
We need to see a formal offer for | DTGoody | investorshub | 05/11/2022 2:29:27 PM |
Moving in the right direction now!!! | DTGoody | investorshub | 05/10/2022 6:37:30 PM |
Loaded both June and July $7.50 calls! Let's | DTGoody | investorshub | 05/10/2022 12:44:36 PM |
:)) | DTGoody | investorshub | 05/04/2022 8:29:15 PM |
Dreamers gotta dream!!! | Clean | investorshub | 05/04/2022 8:05:43 PM |
You Have a Good Day Too my Friend! | DTGoody | investorshub | 05/04/2022 7:34:28 PM |
Could be the fact Nick Abbott did the | budgetthis | investorshub | 05/04/2022 5:18:37 PM |
Wells Fargo places a Buy rating of $45 | DTGoody | investorshub | 05/04/2022 2:44:39 PM |
ABF just strengthened the seriousness of their offer! | Clean | investorshub | 05/03/2022 7:48:42 PM |
We get a second Bidder and this goes | DTGoody | investorshub | 05/03/2022 7:41:06 PM |
Everyone wants a part of us !! $ZYME to | budgetthis | investorshub | 05/03/2022 7:34:43 PM |
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that the Un...
Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from BeiGene and remains eligible to receive up to $164 million based on additional milestones plus royalties on product sales A Biologics License A...
2024-05-15 08:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...